100 Best Against Vaccines Ad Image in 2022-2023
Are you struggling to find the best Against Vaccines ads in 2022-2023?
The best Against Vaccines ads is here! Read the report, learn ad ideas and improve your Against Vaccines ad marketing from high ROI Against Vaccines ads.
With BigSpy, get more high ROI Against Vaccines ads for your ad marketing , such as YouTube ads, Instagram ads, TikTok ads.
Rx Info: http://bit.ly/KBTweA17 IMPORTANT SAFETY INFO: Prevnar 13® should not be given to anyone with a history of severe allergic reaction to any component of Prevnar 13® or any diphtheria toxoid–containing vaccine. Adults with weakened immune systems (eg, HIV infection, leukemia) may have a reduced immune response. In adults, the most common side effects were pain, redness, and swelling at the injection site, limitation of arm movement, fatigue, headache, muscle pain, joint pain, decreased appetite, vomiting, fever, chills, and rash. Ask your healthcare provider about the risks and benefits of Prevnar 13®. Only a healthcare provider can decide if Prevnar 13® is right for you. Patients should always ask their doctors for medical advice about adverse events. You are encouraged to report negative side effects of vaccines to the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC). Visit http://www.vaers.hhs.gov or call 1-800-822-7967. Please see full Prescribing Information (http://bit.ly/KBTweA17). INDICATIONS FOR PREVNAR 13®: Prevnar 13® is a vaccine approved for adults 18 years of age and older for the prevention of pneumococcal pneumonia and invasive disease caused by 13 Streptococcus pneumoniae strains (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F). Prevnar 13® is not 100% effective and will only help protect against the 13 strains included in the vaccine. PREVNAR 13 is a registered trademark of Wyeth LLC. Manufactured by Wyeth Pharmaceuticals LLC. Marketed by Pfizer Inc. PP-PNA-USA-4113-04 © 2020 Pfizer Inc. All rights reserved. July 2020

Rx Info: http://bit.ly/KBTweA17 IMPORTANT SAFETY INFO: Prevnar 13® should not be given to anyone with a history of severe allergic reaction to any component of Prevnar 13® or any diphtheria toxoid–containing vaccine. Adults with weakened immune systems (eg, HIV infection, leukemia) may have a reduced immune response. In adults, the most common side effects were pain, redness, and swelling at the injection site, limitation of arm movement, fatigue, headache, muscle pain, joint pain, decreased appetite, vomiting, fever, chills, and rash. Ask your healthcare provider about the risks and benefits of Prevnar 13®. Only a healthcare provider can decide if Prevnar 13® is right for you. Patients should always ask their doctors for medical advice about adverse events. You are encouraged to report negative side effects of vaccines to the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC). Visit http://www.vaers.hhs.gov or call 1-800-822-7967. Please see full Prescribing Information (http://bit.ly/KBTweA17). INDICATIONS FOR PREVNAR 13®: Prevnar 13® is a vaccine approved for adults 18 years of age and older for the prevention of pneumococcal pneumonia and invasive disease caused by 13 Streptococcus pneumoniae strains (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F). Prevnar 13® is not 100% effective and will only help protect against the 13 strains included in the vaccine. PREVNAR 13 is a registered trademark of Wyeth LLC. Manufactured by Wyeth Pharmaceuticals LLC. Marketed by Pfizer Inc. PP-PNA-USA-4113-02 © 2020 Pfizer Inc. All rights reserved. July 2020

See Rx info: http://tiny.cc/TrumenbaPI. MenB is rare but devastating. Why risk it? Help protect your teen by vaccinating with TRUMENBA at their 16 year old checkup. Ages 16-23 may be at higher risk for MenB, and the CDC immunization schedule highlights MenB vaccination for 16 year olds. Many parents don’t know that the meningitis vaccine (MenACWY) their teen receives at 16 doesn’t cover MenB. Talk to your teen’s doctor or pharmacist about vaccinating with TRUMENBA. IMPORTANT SAFETY INFORMATION • Trumenba should not be given to anyone with a history of a severe allergic reaction after a previous dose of Trumenba • Some individuals with weakened immune systems may have a reduced immune response • Persons with certain complement deficiencies and persons receiving treatments such as Soliris® (eculizumab), are at increased risk for invasive disease caused by Neisseria meningitidis group B even with receipt of vaccination with Trumenba • As with any vaccine, vaccination with Trumenba may not protect all vaccine recipients against N meningitidis group B infections • Fainting can occur in association with administration of injectable vaccines, including Trumenba • The most common adverse reactions in adolescents and young adults were pain at injection site, fatigue, headache, and muscle pain. Nausea was reported in adolescents in early phase studies • Data are not available on the safety and effectiveness of using Trumenba and other meningococcal group B vaccines interchangeably to complete the vaccination series • Tell your health care provider if you are pregnant, or plan to become pregnant • Ask your health care provider about the risks and benefits of Trumenba. Only a health care provider can decide if Trumenba is right for you or your child INDICATION • Trumenba is a vaccine indicated for individuals 10 through 25 years of age for active immunization to prevent invasive disease caused by Neisseria meningitidis group B • The effectiveness of the two-dose schedule of Trumenba against diverse N meni

Rx Info: http://bit.ly/KBTweA17 IMPORTANT SAFETY INFO: Prevnar 13® should not be given to anyone with a history of severe allergic reaction to any component of Prevnar 13® or any diphtheria toxoid–containing vaccine. Adults with weakened immune systems (eg, HIV infection, leukemia) may have a reduced immune response. In adults, the most common side effects were pain, redness, and swelling at the injection site, limitation of arm movement, fatigue, headache, muscle pain, joint pain, decreased appetite, vomiting, fever, chills, and rash. Ask your healthcare provider about the risks and benefits of Prevnar 13®. Only a healthcare provider can decide if Prevnar 13® is right for you. Patients should always ask their doctors for medical advice about adverse events. You are encouraged to report negative side effects of vaccines to the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC). Visit http://www.vaers.hhs.gov or call 1-800-822-7967. Please see full Prescribing Information (http://bit.ly/KBTweA17). INDICATIONS FOR PREVNAR 13®: Prevnar 13® is a vaccine approved for adults 18 years of age and older for the prevention of pneumococcal pneumonia and invasive disease caused by 13 Streptococcus pneumoniae strains (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F). Prevnar 13® is not 100% effective and will only help protect against the 13 strains included in the vaccine. PREVNAR 13 is a registered trademark of Wyeth LLC. Manufactured by Wyeth Pharmaceuticals LLC. Marketed by Pfizer Inc. PP-PNA-USA-4113-01 © 2020 Pfizer Inc. All rights reserved. July 2020


We need your help in the fight against COVID-19. We are looking for volunteers who have not tested positive for COVID-19 to take part in clinical trials investigating potential coronavirus vaccines. This research is critical to the health of all people, not just in the UK, but around the globe. Let’s fight COVID-19 together. Sign up for vaccine trials today.

See Rx info: http://tiny.cc/TrumenbaPI. MenB is rare but devastating, and ages 16-23 may be at higher risk. The CDC highlights MenB vaccination for 16 year olds on the immunization schedule. Many parents don’t know that the meningitis vaccine (MenACWY) their teen receives at 16 doesn’t cover MenB. Why risk it? You can help protect your teen by vaccinating with TRUMENBA at their 16 year old checkup. Talk to your teen’s doctor or pharmacist. IMPORTANT SAFETY INFORMATION • Trumenba should not be given to anyone with a history of a severe allergic reaction after a previous dose of Trumenba • Some individuals with weakened immune systems may have a reduced immune response • Persons with certain complement deficiencies and persons receiving treatments such as Soliris® (eculizumab), are at increased risk for invasive disease caused by Neisseria meningitidis group B even with receipt of vaccination with Trumenba • As with any vaccine, vaccination with Trumenba may not protect all vaccine recipients against N meningitidis group B infections • Fainting can occur in association with administration of injectable vaccines, including Trumenba • The most common adverse reactions in adolescents and young adults were pain at injection site, fatigue, headache, and muscle pain. Nausea was reported in adolescents in early phase studies • Data are not available on the safety and effectiveness of using Trumenba and other meningococcal group B vaccines interchangeably to complete the vaccination series • Tell your health care provider if you are pregnant, or plan to become pregnant • Ask your health care provider about the risks and benefits of Trumenba. Only a health care provider can decide if Trumenba is right for you or your child INDICATION • Trumenba is a vaccine indicated for individuals 10 through 25 years of age for active immunization to prevent invasive disease caused by Neisseria meningitidis group B • The effectiveness of the two-dose schedule of Trumenba against diverse N meningitidis group B strains has


We need your help in the fight against COVID-19. We are looking for volunteers who have not tested positive for COVID-19 to take part in clinical trials investigating potential coronavirus vaccines. This research is critical to the health of all people, not just in the UK, but around the globe. Let’s fight COVID-19 together. Sign up for vaccine trials today.

The CDC recommends that you keep your child’s vaccines up-to-date to protect against diseases. Your pharmacist can help your child get immunized safely against Measles, Mumps and Rubella. It’s free with most insurance.

Young adults ages 16-23 may be at higher risk for MenB. Discuss MenB vaccination with your teen's doctor or a pharmacist at your teen's flu shot visit. The CDC highlights MenB vaccination for 16-year-olds on the imunization schedule. Teens may need 2 separate vaccines to be fully vaccinated against meningococcal disease (MenACWY and MenB). Click the link below to access a Discussion Guide that can help you start the conversation about MenB with your teen's doctor. PP-TRU-USA-2623-03 © 2020 Pfizer Inc. All rights reserved.


We need your help in the fight against COVID-19. We are looking for volunteers who have not tested positive for COVID-19 to take part in clinical trials investigating potential coronavirus vaccines. This research is critical to the health of all people, not just in the UK, but around the globe. Let’s fight COVID-19 together. Sign up for vaccine trials today.

The CDC recommends that you keep your child’s vaccines up-to-date to protect against diseases. Your pharmacist can help your child get immunized safely against Measles, Mumps and Rubella. It’s free with most insurance.
